SG/CALL/NOVO-NORDISK B/1150/0.1/20.06.25 Stock

Warrant

DE000SU9CVV2

Market Closed - Boerse Frankfurt Warrants 03:36:04 2024-06-13 pm EDT
1.21 EUR -2.42% Intraday chart for SG/CALL/NOVO-NORDISK B/1150/0.1/20.06.25
Current month+32.22%
1 month+17.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-13 1.21 -2.42%
24-06-12 1.24 +2.48%
24-06-11 1.21 -5.47%
24-06-10 1.28 +6.67%
24-06-07 1.2 +8.11%

Real-time Boerse Frankfurt Warrants

Last update June 13, 2024 at 03:36 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU9CVV
ISINDE000SU9CVV2
Date issued 2024-02-14
Strike 1,150 kr
Maturity 2025-06-20 (372 Days)
Parity 10 : 1
Emission price 0.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.39
Lowest since issue 0.71
Spread 0.05
Spread %3.97%

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
979.7 DKK
Average target price
929.5 DKK
Spread / Average Target
-5.13%
Consensus